OvaSure is one of the multimarker panels that were made commercially available for ovarian cancer screening. It is made of cancer antigen 125 (CA125), prolactin, leptin, insulin-like growth factor (IGF)-II, macrophage inhibitory factor and osteopontin. Sensitivity has been reported to be 95.3% and specificity 99.4% (50). This panel was available commercially until it was found that an inaccurate ovarian cancer prevalence rate was used to calculate the positive predictive value (PPV) of the test.
OvaSure is one of the multimarker panels that were made
commercially available for ovarian cancer screening. It is made of
cancer antigen 125 (CA125), prolactin, leptin, insulin-like growth
factor (IGF)-II, macrophage inhibitory factor and...
More
Dr. David Fishman of The Mount Sinai Medical Center answered:OvaSure is one of the multimarker panels that were made commercially available for ovarian cancer screening. It is made of cancer antigen 125 (CA125), prolactin, leptin, insulin-like growth factor (IGF)-II, macrophage inhibitory factor and osteopontin. Sensitivity has been reported to be 95.3% and specificity 99.4% (50). This panel was available commercially until it was found that an inaccurate ovarian cancer prevalence rate was used to calculate the positive predictive value (PPV) of the test.OvaSure is one of the multimarker panels that were made commercially available for ovarian cancer screening. It is made of cancer antigen 125 (CA125), prolactin, leptin, insulin-like growth factor (IGF)-II, macrophage inhibitory factor and... More
